Tradestie Institutional Equity Comparison Engine

EW vs SNN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

EW Overall Edge

EW Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Edwards Lifesciences Corp (EW) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while SNN counters with relative strength in Valuation. Fundamentally, EW trades at 31.6x Forward P/E with 28.8% operating margin (+10.5% YoY revenue) versus SNN at 13.2x Forward P/E and 14.2% operating margin (+4.6% YoY). In options structure, EW sits in UNCLASSIFIED (34th %ile IV; Dealer Gamma Walls on Pro) against SNN sits in UNCLASSIFIED (50th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner SNN
EW 31.6x vs SNN 13.2x Fwd P/E
Growth & Margin Winner EW
Op Margin 28.8% vs 14.2% ยท YoY +10.5% vs +4.6%
Momentum & Technical Winner EW
1Y +23.9% vs -5.9% ยท 52W Pos 96% vs 45%
Options & Structure Winner EW
UNCLASSIFIED (34th %ile IV) vs UNCLASSIFIED (50th %ile IV)
EW NYSE
Edwards Lifesciences Corp
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$106.66
-0.46% 1D
Market Cap $60.8B
1M Return +23.16%
1Y Return +23.86%
Forward P/E 31.6x
Unified AI Score
31.5 / 100 SELL
Tech 50.0 Fund 29.0 Flow 51.0 Mom 44.0
SNN NYSE
Smith & Nephew plc
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$31.01
-0.86% 1D
Market Cap $13.2B
1M Return +6.71%
1Y Return -5.94%
Forward P/E 13.2x
Unified AI Score
42.0 / 100 HOLD
Tech 24.0 Fund 37.0 Flow 50.0 Mom 31.2

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: EW +23.86% SNN -5.94% Spread: +29.8 pp (EW Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
EW TTM Op. Margin: 28.8% SNN TTM Op. Margin: 14.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on EW vs SNN. Trailing 12-month operating profitability (EW 28.8% vs SNN 14.2%) and valuation multiples (EW 31.6x vs SNN 13.2x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: EW (6) vs SNN (4)
Institutional Metric EW SNN Criterion Row Winner
Market Capitalization Scale $60.8B $13.2B Larger Scale EW
Trailing P/E Ratio Valuation 61.5x 21.4x Lower Multiple SNN
Forward P/E Ratio Valuation 31.6x 13.2x Lower Multiple SNN
Revenue Growth (YoY) Growth +10.5% +4.6% Higher Growth EW
Operating Margin (TTM) Profitability 28.8% 14.2% Higher Margin EW
Net Profit Margin Profitability 15.3% 10.1% Higher Margin EW
Return on Equity (ROE) Capital Efficiency 9.3% 11.8% Higher ROE SNN
52-Week Range Position Momentum 96% ($75โ€“$108) 45% ($26โ€“$37) Stronger Trend EW
Beta / 30D Volatility Risk Regime 0.44ฮฒ ยท 24% Vol 0.28ฮฒ ยท 38% Vol Lower Realized Risk EW
Unified Institutional Score Composite Signal 31.5 / 100 (SELL) 42.0 / 100 (HOLD) Higher Composite SNN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full EW vs SNN Buy Guide
EW UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 34th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live EW Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SNN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 50th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live SNN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither EW nor SNN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.